학술논문
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia
Document Type
Artikel
Author
Source
Calcified tissue international. 108(5):622-633
Subject
Language
English
English
English
ISSN
1432-0827